Multaq (Dronedarone) for Heart disease

Overview
Multaq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with paroxysmal (sudden and short-lasting episodes) or persistent (continuous) atrial fibrillation (AF) or atrial flutter (AFL). Multaq is also referred to by its drug name, dronedarone.

Multaq is used as a therapy for irregular or rapid heartbeat. Multaq is a member of a class of drugs called anti-arrhythmics. The exact mechanism of action of Multaq is unknown. Multaq is believed to work by inhibiting electrolyte channels in heart muscle cells to prevent abnormal heartbeat.

How do I take it?
Prescribing information states that Multaq is given orally as a tablet twice daily.

Side effects
The FDA-approved label for Multaq lists common side effects that include diarrhea, nausea, abdominal pain, vomiting, and asthenia (general weakness).

Serious side effects listed for Multaq include heart failure, liver damage, abnormal heart electrical activity, and fetal harm.

For more details about this treatment, visit:

Multaq — Sanofi
https://www.multaq.com/

Dronedarone — Michigan Medicine, University of Michigan
https://www.uofmhealth.org/health-library/d07458a1